Cargando…

Treatment self‐regulation questionnaire across three self‐care behaviours: An instrument validation study in Iranian patients with type 2 diabetes mellitus

AIM: The study aimed at testing the validity and reliability of the Persian version of the treatment self‐regulation questionnaire (TSRQ‐15) across healthy diet, exercise and medication‐use/glucose‐monitoring among Iranian people with type‐2 diabetes. DESIGN: Cross‐sectional design. METHODS: Content...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazrati‐Meimaneh, Zahra, Zamanian, Hadi, Shalchi Oghli, Somayyeh, Moradnejad, Shima, Karkehabadi, Fatemeh, Pourabbasi, Ata, Amini‐Tehrani, Mohammadali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190691/
https://www.ncbi.nlm.nih.gov/pubmed/35489055
http://dx.doi.org/10.1002/nop2.1219
Descripción
Sumario:AIM: The study aimed at testing the validity and reliability of the Persian version of the treatment self‐regulation questionnaire (TSRQ‐15) across healthy diet, exercise and medication‐use/glucose‐monitoring among Iranian people with type‐2 diabetes. DESIGN: Cross‐sectional design. METHODS: Content validity was investigated by 16 experts. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were employed. Construct validity, convergent/discriminant validity and internal consistency were examined. Concurrent validity was assessed using Spearman's rho correlation across different behaviours. RESULTS: Content validity was confirmed for Persian TSRQ‐15. A three‐factor structure was revealed, in which external regulation and introjected regulations were validated, while amotivation and autonomous failed to show discriminant validity. Internal consistency was sound, and concurrent validity was approved. The Persian version of TSRQ‐15 was shown to be a valid and reliable tool for assessing motivation behind the practice of healthy diet, exercise and medication‐use/glucose‐monitoring in people with type 2 diabetes.